Article
Chronotherapy as a Potential Strategy to Reduce Ifosfamide-Induced Encephalopathy: A Preclinical Study in a Murine Model
2025-09-03
Abstract excerpt
<h4>Purpose</h4> Nearly five decades after its introduction into clinical oncology, ifosfamide (IFO) remains a widely used alkylating chemotherapeutic agent for the treatment of sarcomas, germ-cell tumors and selected hematological malignancies in both adult and pediatric oncology. Its use is limited by severe toxicities, particularly hemorrhagic cystitis and central nervous system complications. Recent studies h...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7293c7c-b5f1-5307-b164-4bd087112c6b
- DOI
- 10.1101/2025.08.28.672634
